Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”
Excerpt
Reply: Thank you for the valuable comments. We agree with the concern that distinguishing genuine circulating tumor cells (CTCs) from other circulating cells by morphology may be questionable.[...]
Share and Cite
Alama, A.; Coco, S.; Vanni, I.; Grossi, F. Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”. Int. J. Mol. Sci. 2017, 18, 1309. https://doi.org/10.3390/ijms18061309
Alama A, Coco S, Vanni I, Grossi F. Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”. International Journal of Molecular Sciences. 2017; 18(6):1309. https://doi.org/10.3390/ijms18061309
Chicago/Turabian StyleAlama, Angela, Simona Coco, Irene Vanni, and Francesco Grossi. 2017. "Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”" International Journal of Molecular Sciences 18, no. 6: 1309. https://doi.org/10.3390/ijms18061309
APA StyleAlama, A., Coco, S., Vanni, I., & Grossi, F. (2017). Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”. International Journal of Molecular Sciences, 18(6), 1309. https://doi.org/10.3390/ijms18061309
